Tasonermin

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTasonermin
Drug Alias NameTNF alpha-1a他索纳明tasonerminumTumour necrosis factor alphatasonermina +[9] 
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsSarcoma
Global Approved IndicationsSarcoma
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date1999/04/12
Country/TerritoryEU
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesC.H. Boehringer Sohn Ag & Co. Kg
China Registration ClassN/A

Develop Information

Active CompaniesBelpharma Sa
Inactive CompaniesN/A
Active IndicationsSarcoma
Inactive IndicationsN/A

Other Information

ATC CodeL03AX11
Related LinksKEGG